Crossmark

Evaluation of the PARACHUTE-HF trial: role of sacubitril/valsartan compared to enalapril on outcomes in patients with heart failure from Chagas’ disease

Crossref DOI link: https://doi.org/10.1007/s10741-026-10617-3

Published Online: 2026-03-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abramov, Dmitry

Minhas, Abdul Mannan Khan

Alexy, Tamas

Guimaraes, Patricia Oliveira

Lainscak, Mitja

Myhre, Peder L.
Funding

Funding for this research was provided by:

Loma Linda University
License Information

Text and Data Mining valid from 2026-03-30

Version of Record valid from 2026-03-30
More Information

Article History

Received: 22 September 2025

Revised: 25 February 2026

Accepted: 16 March 2026

First Online: 30 March 2026

Declarations

:

: Not applicable.

: No relevant disclosures.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below